Panagora Asset Management’s Vir Biotechnology VIR Stock Holding History

Panagora Asset Management’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.81M	Sell	374,265 -1,089	-0.3%	-$10.4K	0.01%	503
2026 Q1	$3.36M	Buy	375,354 +4,063	+1%	+$32.4K	0.01%	486
2025 Q4	$2.24M	Buy	371,291 +10,874	+3%	+$64.7K	0.01%	543
2025 Q3	$2.06M	Buy	360,417 +263,090	+270%	+$1.35M	0.01%	522
2025 Q2	$491K	Buy	+97,327	New	+$522K	﹤0.01%	802
2024 Q1	–	Sell	-94,516	Closed	-$951K	–	1261
2023 Q4	$951K	Buy	+94,516	New	+$864K	0.01%	834
2023 Q2	–	Sell	-20,953	Closed	-$488K	–	1495
2023 Q1	$488K	Buy	+20,953	New	+$536K	﹤0.01%	1129

Other funds holding VIR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GSK plc London $602M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Panagora Asset Management's VIR Position: Q2 2026 in Review

Panagora Asset Management reduced its Vir Biotechnology (VIR) stake by 0.29% in Q2 2026, selling an estimated $10.4K and leaving 374,265 shares worth $3.81M. The position accounts for 0.01% of the portfolio, ranked #503.

Panagora Asset Management first reported a position in VIR in Q1 2023 and has held it in 7 quarters since. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

Panagora Asset Management held 374,265 shares of Vir Biotechnology worth $3.81M as of Q2 2026.
Panagora Asset Management sold 1,089 Vir Biotechnology shares in Q2 2026, an estimated $10.4K.
Vir Biotechnology made up 0.01% of Panagora Asset Management's portfolio in Q2 2026, its #503 holding.
Panagora Asset Management first reported a position in Vir Biotechnology in Q1 2023 and has held it in 7 quarters since.
237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.